Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
Submitted by
admin
on March 5, 2016 - 9:50am
Source:
Fierce Pharma
News Tags:
JNJ
AbbVie
Imbruvica
CLL
FDA
chronic lymphocytic leukemia
Headline:
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
Do Not Allow Advertisers to Use My Personal information
